Participated · Seed · May 2026

Tribal builds an enterprise-native AI platform that develops context-aware AI agents which learn the metadata graph of an organization’s systems. The company integrates with major enterprise platforms and plans product expansion across Salesforce, ServiceNow, SAP, NetSuite, and Workday. Tribal is headquartered in New York City and is led by CEO Yoav Kolodner, COO Yakir Daniel, and CTO Lior Sidi. Following its $10M Seed raise, the company plans to accelerate U.S. expansion and hiring. The articles do not provide revenue, user, or other operating metrics.

Participated · Series A · Apr 2026

Scentian Bio develops a palm-sized sensor-on-a-chip that combines insect-inspired sensing with AI to identify complex combinations of volatile organic compounds. The device aims to deliver near-real-time, easy-to-interpret results for use cases including food spoilage detection, air-quality monitoring, and the detection of explosives or pests. The company reports it is working with seven global leaders in food, beverages and condiments as it nears commercial launch. Cofounders Andrew Králíček and Jonathan Good envision the technology eventually migrating into consumer devices such as smartwatches and handsets. The startup is months away from market and has just raised $7M in a pre-Series A to support product completion and commercialization.

Led · Seed · Mar 2026

Tess AI offers an enterprise agent-orchestration platform whose multi-model engine stitches together over 250 AI models—including Claude, GPT, Gemini, and Qwen—so employees can build autonomous agents for tasks like bank reconciliation, inventory checks, prospecting, data analysis, and internal reporting. Instead of traditional per-seat SaaS licenses, the company charges for completed work, positioning itself as a “seatless” solution that removes budget friction and encourages bottom-up adoption. In the past 12 months, more than 16,000 employees have onboarded to the platform, and the system executed more than 600,000 autonomous agent tasks in the last month alone, with individual agents handling up to 40 simultaneous operations per call. Founded by Brazilian entrepreneurs and led by CEO Rica Barros, Tess AI argues it delivers more than 3× ROI in the first year of deployment. The firm competes with offerings from Microsoft, IBM, UiPath, Automation Anywhere, CrewAI, and Relevance AI, but differentiates through its broad model coverage and usage-based economics. The recent seed financing pegs the company’s valuation at roughly R$200 million (about US$35 million), giving it fresh capital to scale its orchestration engine and expand go-to-market efforts. Management plans to deploy the new funds to deepen model integrations and accelerate enterprise adoption of its “Vibe Working” performance framework.

Led · Seed · Sep 2025

Immuto Scientific is developing an AI-powered structural surfaceomics platform that integrates high-resolution proteomics, live-cell protein structural assessment, and advanced analytics to uncover novel, disease-specific surface protein conformations. By mapping these previously invisible epitopes, the company aims to generate highly selective drug targets, initially focusing on oncology but with plans to expand into immunology and inflammation. Immuto’s approach promises improved therapeutic indices by minimizing overlap with healthy tissue, thereby reducing toxicity. The platform has already identified targets across multiple tumor types, and the company is advancing its lead oncology program through in-vivo studies with the goal of entering IND-enabling work. In addition to building its internal pipeline, Immuto collaborates with pharmaceutical partners; its first partnership with Daiichi Sankyo will co-discover solid-tumor targets and develop antibodies against them. Backed by recent financing, the company will scale its discovery efforts and deepen its data-driven engine to fuel future therapeutics. No revenue or user metrics were disclosed in the articles.